Austin, TX 10/16/2007 9:20:53 PM
Speak with other shareholders about: (OTCBB: ETLC), (NASD: TELK), (OTC: IGRU), (OTCBB: APDN)
AUSTIN, TX: October 16, 2007 – Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the “Chat Live” button at the top.
----------------------------------------------------------
Chat real-time with other investors about this ETLC news release, by clicking this link: http://www.stockwire.com/ETLC
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=ETLC
ETELCHARGE.COM INC (OTCBB: ETLC)
Etelcharge.com (OTCBB: ETLC), the first Web 2.0 online payment system, provides online shoppers the ability to charge approved transactions to their telephone bill. While addressing the concerns online shoppers have about identity fraud and identity theft, the Etelcharge payment option is also a perfect match for the millions of individuals without a credit card, or even a bank account. For more information, go to www.etelcharge.com.
ETLC News:
October 11 - Robyn Priest Appointed Chief Financial Officer
Etelcharge.com (OTCBB: ETLC) (www.etelcharge.com), the new online way to pay(TM), today announced that Robyn Priest has been appointed Chief Financial Officer.
Priest was formerly a Vice President and Assistant Treasurer of CompUSA.
Robyn has a distinguished background, having previously served as a finance executive in public companies. She has also served in the capacity of Chief Financial Officer. Robyn injects solid business discipline and strict business control procedures. Her background and experience in the detailed specifics of retail finance and online merchant sales are a great complement to Etelcharge's business model. Robin Priest is a Certified Public Accountant and a graduate of the University of South Florida.
"I am excited about the direction and the opportunity as Etelcharge is transformed into a full-fledged service and marketing organization," Priest stated. "I look forward to fulfilling my role on the management team as we take the Company to the next level and fulfill all consumer, vendor and regulatory requirements. Along with that, I believe my role in solidifying strategic alliances, joint ventures and vendor agreements from a financial standpoint will assist in our anticipated growth," she concluded.
"Robyn brings the expertise, the energy and the tenacity we need on our management team," said Rob Howe, Chairman and CEO of Etelcharge. "As we take this business forward, Robyn will have far and away the bandwidth necessary for us to handle the complexities we'll face in the days ahead. She's a pro. I'm grateful she has joined us as the permanent CFO."
About Etelcharge.com
Etelcharge.com (OTCBB: ETLC), the first Web 2.0 online payment system, provides online shoppers the ability to charge approved transactions to their telephone bill. While addressing the concerns online shoppers have about identity fraud and identity theft, the Etelcharge payment option is also a perfect match for the millions of individuals without a credit card, or even a bank account. For more information, go to www.etelcharge.com.
----------------------------------------------------------
Chat real-time with other investors about this TELK news release, by clicking this link: http://www.stockwire.com/TELK
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=TELK
TELIK INC (NASD: TELK) "Up 28.03% in morning trading"
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced drug development candidates are TELCYTA, a tumor-activated small molecule product candidate in clinical development for the treatment of advanced ovarian cancer and non- small cell lung cancer; and TELINTRA(R), which is in clinical development for the treatment of myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates.
TELK News:
October 15 - FDA Removes Partial Hold on TELCYTA Clinical Development
Telik, Inc. (Nasdaq: TELK) announced that the U.S. Food and Drug Administration (FDA) has removed the partial hold on TELCYTA(R) (canfosfamide HCl, TLK286) clinical trials. This action follows a complete review of TELCYTA data by the agency and permits the resumption of TELCYTA clinical development.
----------------------------------------------------------
Chat real-time with other investors about this IGRU news release, by clicking this link: http://www.stockwire.com/IGRU
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=IGRU
INTERNATIONAL GOLD RESOURCES (OTC: IGRU) "Up 35.71% in morning trading"
The vision of International Gold Resources, Inc. is to maximize shareholder value by becoming recognized as one of the premier early stage gold exploration and development companies.
IGRU News:
October 15 - International Gold Resources, Inc. Announces the Discovery of a Large Manganese Target at Cupixi, Amapa State, Brazil
International Gold Resources, Inc. (OTC: IGRU) announced today that the Company has discovered a large manganese target on its Cupixi claim block in Amapa State, Brazil. The target is estimated by IGR's geologic consultant in Brazil, Tobias Geotec, to be a minimum of 30 to 50 million metric tonnes of Manganese oxide ore. This estimate is based on projected depths of at least 30 meters. Assumptions were made on mining and processing losses for ore quality upgrades. The surface area delineated is 2 km by 0.7 km. Within this area are several manganese outcrops up to 150 meters in length. Soil samples, trenches, and auger holes were used in delineating the surface area and indicated depth. The estimate is not compliant with Securities and Exchange Commission and Canadian NI43-101 standards. IGR has commenced core drilling and expects to confirm depth and mineralization continuity estimates over the next several weeks.
Mike Michels, IGR's Vice President of Brazilian operations said, "Tobias Geotec is one of Brazil's premier technical consultants. With their support, our own core drilling underway, and the oversight of Behre Dolbear, we are expecting to advance the Cupixi manganese target quickly. The Porto Grande area, where our Cupixi claims are located, is an historic manganese producing area with good infrastructure."
Behre Dolbear estimated manganese ore value delivered to Port at approximately $75 per metric tonne in their June 2007 preliminary evaluation of IGR's Brazilian assets. The full Behre Dolbear report can be viewed on the IGR Internet site, "www.intlgold.com".
IGR commissioned Tobias Geotec to perform the necessary work on the Cupixi claim area in support of IGR's application for permit extensions. IGR has timely filed the applications with the governing Brazilian authorities. IGR has commissioned Behre Dolbear to work in conjunction with Tobias Geotec to independently verify work quality as IGR proceeds with advancing the project.
----------------------------------------------------------
Chat real-time with other investors about this APDN news release, by clicking this link: http://www.stockwire.com/APDN
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=APDN
APPLIED DNA SCIENCES (OTCBB: APDN) "Up 25% in morning trading"
Applied DNA Sciences, Inc. provides botanical DNA encryption, embedment and authentication solutions that can help protect companies, governments and consumers from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion into physical locations and databases. APDN's common stock is listed on the Over-The-Counter Bulletin Board under the symbol "APDN".
APDN News:
October 12 - Applied DNA Sciences Closes on Initial Bridge Financing and Receives Third Milestone Payment in Supima Agreement; CEO Increases Personal Investment in Company
Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of DNA-based security solutions, today announced that it has recently closed on initial rounds of bridge financing totaling $550,000. This financing is in the form of secured convertible promissory notes and warrants to purchase shares of the company's common stock.
"The ability of APDN to continue to raise money at this critical juncture proves once again that the company is moving forward with its commercialization strategy and I believe that other investors are as optimistic as I am about the future of this company," commented Dr. James Hayward, APDN's President and CEO.
In another positive development, APDN received its third milestone payment from Supima, the promotional organization of the American Pima cotton growers. This milestone demonstrates Supima's continued commitment to this study and the organization continues to be excited by the results to date. APDN has been able to successfully amplify DNA from mature cotton cultivars, the first group in the world that has been able to do so, and patent applications have been filed to protect this important finding.
"We believe that there will be strong market demand for testing of cotton cultivars to distinguish between American Pima cotton and other cotton, once we successfully complete this feasibility study," Dr. Hayward continued. "There is an urgent need for this testing, not only in industry, but we believe also by the US government, looking to monitor and control the entry of foreign textiles into the US market. We believe this testing, which would be done solely by APDN, represents the potential to generate substantial revenue for the company. We are very encouraged by our results to date and are excited by the potential opportunity these findings represent."
Dr. Hayward has also increased his personal investment in APDN in the amount of $300,000. This is in addition to the $550,000 announced previously, bringing his total investment in the company over the past six months to $850,000.
Dr. Hayward added, "I believe that the greatest expression of my confidence in APDN is the fact that I continue to invest my personal funds into the company. We continue to make progress on a daily basis and the entire management team is committed to doing what is necessary for APDN to realize its potential."
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE RESEARCH GROUP INC..
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com, which is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares at any given time.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
